Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RNAZthis companyTransCode Therapeutics, Inc.	$1.53	-0.13×	0.46×	0×	0.38×	1495.1%	0.0%	0.0%	0.0%	-335.4%	-17.6%	-414.4%	0×	0.52×	-4,229.15×	6.29×	0.0%	0	-1.94	3	B
ACXPAcurx Pharmaceuticals, Inc.	$1.06	-0.47×	0.71×	0×	0.48×	374.0%	0.0%	0.0%	0.0%	-151.2%	-153.6%	-181.9%	0×	0.95×	0×	3.18×	0.0%	2	-10.22	2	B-
APREAprea Therapeutics, Inc.	$0.51	-0.44×	0.45×	0×	0.72×	335.0%	0.0%	0.0%	0.0%	-101.3%	-100.5%	-231.2%	0×	1.16×	0×	5.63×	0.0%	3	-10.16	2	C+
APVOAptevo Therapeutics Inc.	$1.18	-0.11×	0×	0×	0.66×	379114.3%	0.0%	0.0%	0.0%	-149.4%	-119.5%	-86018.8%	0.27×	0.66×	0×	3.82×	0.0%	1	-33.17	2	B-
BOLTBolt Biotherapeutics, Inc.	$6.45	-0.31×	0.39×	1.33×	-0.67×	-1476.7%	80.6%	-450.1%	-433.7%	-125.9%	-67.7%	-390.3%	0.87×	-0.35×	0×	3.59×	0.0%	2	-18.11	2	C
HCWBHCW Biologics Inc.	$1.02	-0.09×	0.74×	37.52×	-1.22×	-4178.9%	20.0%	-20757.6%	-14677.1%	-287.9%	-109.7%	-658.1%	2.46×	-0.86×	-9×	0.11×	0.0%	2	-6.89	2	C
Peer median	—	-0.31×	0.45×	0×	0.48×	335.0%	0.0%	0.0%	0.0%	-149.4%	-109.7%	-390.3%	0.27×	0.66×	0×	3.59×	0.0%	2	-10.22	2	—